EarlySense Chair Sensor Receives FDA Clearance - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
EarlySense Chair Sensor Receives FDA Clearance Expanding Contact-Free and Continuous Monitoring to Out-of-Bed Patients


EarlySense Chair Sensor Receives FDA Clearance

Expanding Contact-Free and Continuous Monitoring to Out-of-Bed Patients

PR Newswire

WALTHAM, Massachusetts, July 2, 2014 /PRNewswire/ --

EarlySense®, the market leader in contact free monitoring solutions today announced the market clearance by the US Food and Drug Administration for the Chair Sensor Solution. The Chair Sensor, which continuously monitors patient's Heart Rate, Respiratory Rate and Movement, was recently evaluated at Coffee Regional Medical Center where it successfully enabled the clinical team to proactively respond to early signs of Patient Deterioration and to prevent Patient Falls.  This is the first contact free sensor for vital signs in a chair.

Clinicians have long known that ambulating patients from bed to chair improves healing, reduces the risk of complications and shortens length of stay. Moving around in an upright position appears to be of most benefit in the early post-operative period and to improve lung function and reduce potential pulmonary complications.[1] But to date there was not automatic contact-free solution for keeping patients safe in their chairs.

Continuous patient monitoring is a key factor in recognizing and promptly responding to early warning signs, and facilitates timely interventions for non-ICU patients. Peer reviewed clinical trials have shown that responding to early warning signs significantly improve patient safety and hospitals' economic outcomes. The EarlySense Chair Sensor is the tool that empowers clinical staff to provide proactive effective, timely interventions when patients are deteriorating or at risk of falling, therefore, accelerating recuperation and reducing risks.

"The chair sensor fits the workflow here very nicely," said SueLane Hughes, Director Medical/OPO Unit at Coffee Regional Medical Center. "The biggest advantage of the chair sensor is that it monitors the patient when sitting on the chair and doesn't require any user contact. We found it to be very useful in giving the clinical team information about their patients, no matter if they were in bed or sitting in the chair. The EarlySense System is allowing the medical staff to recognize potential adverse events prior to them becoming acute events that potentially put patients in jeopardy. The chair sensor is another tool to assist us in preventing patient falls by getting staff into patients' rooms before they have exited the chair. Since we started using the chair sensor we have had zero patient falls from chairs."

According to Avner Halperin, CEO of EarlySense, "Medical institutions have often expressed the need for automatic sensing in chairs. Hospitals have used the EarlySense bed sensor solution to make their beds a smart, safe place for more than 100,000 patients. Hospitals have shown us that they value smart beds, now for the first time they can get 'smart chairs'. In addition, with a chair sensor we believe that a number of other clinical environments will open up to the EarlySense System, such as Emergency Departments, Outpatient Clinics and waiting areas where concern around patients may exist and today there is no practical way to monitor patients."

--------------------------------------------------

1. http://www.nursingtimes.net/nursing-practice-clinical-research/acute-care/enhanced-recovery-pathway-in-colorectal-surgery-2-post-operative-complications/5004410.article

About EarlySense

EarlySense, the market leader in Contact-free and Continuous patient monitoring, assists clinicians in early detection of patient deterioration and in identifying and preventing potential adverse events such as patient falls and pressure ulcers. The company's solutions monitor patient's heart and respiratory rate, as well as movement, with a unique sensor that is placed under the mattress. The system was designed to address safety challenges on general care floors as well as failure to rescue of those patients who are usually monitored by nursing staff approximately once every four to eight hours. EarlySense also offers OEM solutions for companies looking to expand their products by providing contact-free and continuous sensing capabilities.

EarlySense International headquarters is in Israel, and US headquarters is in Waltham, MA, the EarlySense System is currently installed in hospitals and rehabilitation centers in USA, Europe, Asia and Australia. For more information, visit EarlySense.com.

Follow us on Twitter.
Like us on Facebook.

Media Contact (US):
Maayan Wenderow
maayan.wenderow@earlysense.com
+1-617-971-6464

Media Contact (International):
Hila Peleg
Hila.Peleg@earlysense.com
+972-54-527-3117

 

SOURCE EarlySense

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here